Zynerba Pharmaceuticals
Agent22Agent Readiness: 22/100. Bottom 25%. Measured by StartupHub.ai. Median 41.Pharmaceutical company developing transdermal cannabinoid therapeutics for behavioral and emotional conditions.
About
Zynerba Pharmaceuticals was a specialty pharmaceutical company focused on developing and commercializing novel transdermal cannabinoid therapeutics. Their lead product candidates were designed to treat behavioral and emotional symptoms associated with conditions such as Fragile X syndrome, developmental and epileptic encephalopathies, and peripheral neuropathic pain. The company aimed to leverage the therapeutic potential of cannabinoids through innovative drug delivery systems.
Key facts
At-a-glance profile data
- Website
- zynerba.com
- Headquarters
- Wayne, United States
- Founded
- 2007
- Total funding
- -
- Business model
- B2B
Tech stack
Detected on zynerba.com, last scanned 23 May 2026. Run your own scan
- Analytics
- Google Tag Manager
- CMS / Builders
- WordPress
- CDN
- Cloudflare
- Email provider
- Mimecast
- Video / media
- Vimeo
Frequently asked
What is Zynerba Pharmaceuticals's current status?
Zynerba Pharmaceuticals's current operating status is: Inactive.